Singapore markets closed

STRATA Skin Sciences, Inc. (SSKN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3936+0.0120 (+3.14%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.38M
Enterprise value 22.23M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.40
Price/book (mrq)1.05
Enterprise value/revenue 0.67
Enterprise value/EBITDA -7.01k

Trading information

Stock price history

Beta (5Y monthly) 1.54
52-week change 3-61.39%
S&P500 52-week change 326.49%
52-week high 31.0800
52-week low 30.2600
50-day moving average 30.4676
200-day moving average 30.5400

Share statistics

Avg vol (3-month) 328.14k
Avg vol (10-day) 324.46k
Shares outstanding 535.06M
Implied shares outstanding 638.59M
Float 811.94M
% held by insiders 16.04%
% held by institutions 166.30%
Shares short (30 Apr 2024) 427.95k
Short ratio (30 Apr 2024) 40.87
Short % of float (30 Apr 2024) 40.15%
Short % of shares outstanding (30 Apr 2024) 40.08%
Shares short (prior month 28 Mar 2024) 4215.19k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 307 Apr 2017
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 307 Apr 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -32.47%
Operating margin (ttm)-13.32%

Management effectiveness

Return on assets (ttm)-8.38%
Return on equity (ttm)-62.75%

Income statement

Revenue (ttm)33.36M
Revenue per share (ttm)0.95
Quarterly revenue growth (yoy)-18.00%
Gross profit (ttm)N/A
EBITDA -767k
Net income avi to common (ttm)-10.83M
Diluted EPS (ttm)-0.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.78M
Total cash per share (mrq)0.19
Total debt (mrq)15.63M
Total debt/equity (mrq)123.21%
Current ratio (mrq)1.28
Book value per share (mrq)0.36

Cash flow statement

Operating cash flow (ttm)-519k
Levered free cash flow (ttm)-3.04M